Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Japan gives preliminary OK to 2 more COVID-19 vaccines

A Japanese health ministry drug safety panel has given preliminary approval to coronavirus vaccines developed by Moderna and AstraZeneca ahead of an expansion next week of the country’s slow-paced immunization program before the Tokyo Olympics

Via AP news wire
Thursday 20 May 2021 09:41 EDT
Virus Outbreak Japan Daily Life
Virus Outbreak Japan Daily Life (Copyright 2021 The Associated Press. All rights reserved)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A Japanese health ministry drug safety panel on Thursday gave preliminary approval to coronavirus vaccines developed by Moderna and AstraZeneca ahead of an expansion next week of the country's slow-paced immunization program before the Tokyo Olympics.

The only COVID-19 vaccine currently approved for emergency use in Japan is developed by Pfizer Inc.

Formal approval of the two additional vaccines is expected Friday by a broader vaccine policy panel, officials said.

Health Minister Norihisa Tamura said approval of the additional vaccines will help speed up inoculations. Japan has administered one or more vaccine doses to roughly 5 million people, or just 4% of the population.

As the government pushes to host the Olympics in about two months, accelerating vaccinations is key to warding off mounting public concern about the safety of the event. Recent polls have found that more than 80% of Japanese oppose hosting the Olympics this summer.

Prime Minister Yoshihide Suga has pledged to finish vaccinating the country’s roughly 36 million elderly population by the end of July, when the games are to be held. However, a government survey of 1,741 municipalities released last week found around 15% will not be able to meet the deadline.

On Monday, the government will open mass-vaccination sites in two of the country’s biggest metropolitan areas, Tokyo and Osaka with the goal of administering vaccines to up to 15,000 elderly people a day. Moderna shots are to be used at the sites.

Japan has secured around 364 million vaccine doses, including 50 million of the Moderna vaccine through a contract with Tokyo-based Takeda Pharmaceutical, 120 million from AstraZeneca, and 194 million from Pfizer. All three vaccines require two doses.

___

Associated Press writer Mari Yamaguchi contributed to this report.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in